Using a yeast two hybrid system and pull-down assays we demonstrate that mouse Dac (mDac) speci®cally binds to mouse ubiquitinconjugating enzyme mUbc9. In contrast to a direct interaction between Drosophila dachshund (dac) and eyes absent (eya)gene products, we cannot detect by the same methods that mDac binds to mEya2, a functional mouse homologue of the Drosophila Eya. Immunostaining of various cell lines that were transfected with mDac reveals that mDac protein is found predominantly in the nucleus but translocates to the cytoplasm and condensates along the nuclear membrane in a cell-cycle dependent manner. Deletion analysis of mDac show the intracellular localization and protein stability correlates with the binding to mUbc9. The C-terminal half of mDac, which associates with mUbc9, remains cytoplasmic and is degraded in proteasome whereas the non-interacting N-terminus is exclusively nuclear and more stable than the fulllength mDac or its C-terminal portion. In situ hybridization on whole-mount embryos or tissue sections detects mUbc9 transcripts in complementary and overlapping areas with mDac expression, particularly in the proliferation zone of the limb buds, the spinal cord and forebrain. Mouse embryos stained with an anti-mDac antibody document that mDac is localized both in the nucleus and the cytoplasm with a cytoplasmic predominance in migrating neural crest cells. In the proliferation zone, visible nuclear envelopes are not formed and mDac is detected throughout the cells. q
Introduction
The Drosophila dachshund gene (dac) was ®rst identi®ed in mutants showing characteristic shortened legs and few or no ommatidia (Mardon et al., 1994) . dac expression is found in the imaginal discs of eyes/antennae, legs and wings as well as in the central nervous system (Mardon et al., 1994) . In the eye imaginal disc, dac null mutants show a subset of phenotypes that affect initiation of the morphogenetic furrow (MF) and neuronal development. In the leg, Dac is required for development of the femur and tibia (Mardon et al., 1994; Abu-Shaar and Mann, 1998) . When dac is misexpressed by a dpp-Gal4 driver, ectopic eye formation is induced (Chen et al., 1997; Shen and Mardon, 1997) . In the eye, Dac forms a functional network with other nuclear factors including eyeless (ey)/twin of eyeless (toy), eyes absent (eya), sine oculis (so) and teashirt (tsh) (Chen et al., 1997; Pignoni et al., 1997; Halder et al., 1998; Czerny et al., 1999; Pan and Rubin, 1998) . Combinatorial ectopic expression of dac/eya or so/eya leads to higher penetrance and eye induction in a broader range of locations than with dac, so or eya alone Chen et al., 1997; Pignoni et al., 1997; Shen and Mardon, 1997) .
Several lines of evidence suggest that eya, so and dac act downstream of ey: (i) ey/toy expression is earlier than the expression of eya, so and dac; and (ii) ey/toy is required for the initial expression of eya, so and dac. However, a simple linear pathway is unlikely since eya, so, dac and tsh are involved in multiple positive feed-back loops to activate ey expression (Halder et al., 1995; Bonini et al., 1997; Chen et al., 1997; Desplan, 1997; Pignoni et al., 1997; Shen and Mardon, 1997; Halder et al., 1998; Pan and Rubin, 1998; Czerny et al., 1999) .
Biochemical analysis has demonstrated that Drosophila Dac and Eya can physically associate through evolutionary conserved domains (Chen et al., 1997; Shen and Mardon, 1997) . Furthermore, Eya can form a physical complex with So (Pignoni et al., 1997) . It has been proposed that Dac provides speci®city to an Eya-So complex for MF initiation but it is not required for MF progression (Chen et al., 1997) .
Others and we have recently isolated mDac, a mouse homologue of Drosophila dac (Hammond et al., 1998; Caubit et al., 1999) . mDac is expressed in several tissues including the neocortex, the neural crest, the genital eminence and the progress zone of the limb buds. Furthermore, high levels of human Dac (hDac) expression are found in neuroblastomas (Kozmik et al., 1999) . Vertebrate and Drosophila Dac contain conserved N-terminal domain that shows homology to the Ski/sno family of proto-oncogenes and therefore we termed this domain SSD (Hammond et al., 1998; Caubit et al., 1999; Kozmik et al., 1999) . Human Dac maps to chromosome 13q22.3±13q23, a locus that is associated with various congenital abnormalities and mental retardation (Caubit et al., 1999; Hammond et al., 1999) . In several areas, mDac expression overlaps with the expression of mouse Eya homologues, but mDac is also expressed in mouse tissues, including the progress zone of the limb buds, where no vertebrate Eya expression has been reported (Xu et al., 1997; Caubit et al., 1999) . In contrast to the Drosophila dac/ey dependence, Hammond et al. (1998) do not ®nd a direct dependence of mDac on Pax6, the vertebrate orthologue of ey. Recently, a novel chicken gene cDach2 with a sequence homology to Drosophila dac has been characterized (Heanue et al., 1999) . cDach2 synergizes together with Six1 and Eya2 to regulate myogenic differentation in Pax3 dependent manner. Our ®rst goal was therefore to establish whether mouse Dac interacts with vertebrate Eya homologues. To our surprise we cannot con®rm such an interaction with the methods used. Instead we ®nd that mDac associates with the cell-cycle controlling factor mUbc9.
Results

mUbc9, but not mEya2 binds mouse Dac in vitro
Drosophila Eya has been shown to bind Dac (Chen et al., 1997) . We were therefore interested in whether an Eya-Dac interaction can be observed in vertebrates. Three mouse homologues of the Drosophila eya gene have been isolated (Xu et al., 1997; Zimmerman et al., 1997) and mEya2 has been documented to be a functional homologue of Drosophila Eya . Mouse full-length mEya2 cDNA, or the C-terminal conserved region, were cotransfected with mouse mDac 157±751 (lacking the N-terminal polyserine repeat, from position 157±751) into yeast strain CG1945. Positive clones for an interaction between mDac and mEya2 would yield a phenotype that allows yeast strain CG1945 to grow in His3-def®cient media and to express lacZ. Surprisingly, no positive colonies, which would indicate a mEya2/mDac interaction, could be detected in three parallel experiments (Fig. 1A) . Furthermore, in vitro translated mDac is not co-precipitated with GST-mEya2 under the applied conditions (Fig. 1B) .
We therefore carried out yeast two-hybrid screens with the cDNA of mDac 157±751 as a bait. Two independent libraries were screened: (i) a mouse 11 dpc embryo cDNA MATCHMAKER library utilizing a GAL4 activation domain (GAL4-AD); and (ii) a mouse 10.5 dpc embryo cDNA library based on a VP16 activation domain (VP16-AD). Both embryonic stages show high levels of mDac expression in forebrain, dorsal hindbrain/spinal cord, neural crest and limb buds (Caubit et al., 1999) and should therefore be suitable for isolating mDac binding partners. A total of 40 His3/LacZ positive colonies were obtained from the GAL4-AD library, while 16 His3/LacZ positive colonies were isolated from the VP16-AD library. None of the obtained positive clones contained mEya related sequences. However, 39 of 40 colonies from the GAL4-AD library showed cDNA inserts that were identical to mouse mUbc9.-Nine of these mUbc9sequences differed both in the size and junction site of AD fusion and therefore they represent independent isolates. Likewise, 12 of 16 colonies obtained from the VP16-AD library contained mUbc9inserts, eight of the clones were independent. mUbc9 and mDac 157-751 also showed positive His3/lacZ colonies when re-introduced into yeast cells. To con®rm the mDac-mUbc9 interaction in vitro, full-length mUbc9-GST coupled to glutathioneagarose beads was incubated under physiological salt conditions with in vitro translated mDac. As shown in Fig. 1B , in vitro translated mDac is precipitated with GST-mUbc9.
Sequence analysis of all mUbc9 clones obtained from the two screens revealed that the minimal mUbc9 sequences in positive colonies spanned from position Ala 5 to Pro
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. Liu et al. (1999a Liu et al. ( , 1999b have predicted two¯exible regions in human UBC9 that is 100% identical in its amino acid sequence to mUbc9. The C-terminal¯exible region of human Ubc9 has been suggested to play a role in substrate binding. This includes helix 2 and 3, which have a positive electrostatic potential, and a number of conserved residues outside of these helices. With regard to mDac, only helix 2 and residues up to Leu 119 of mUbc9 are required to produce colonies in the yeast two-hybrid system. Deletion series of the mDac cDNA was carried out to map more precisely an area of mDac that interacts with mUbc9. mDac contains two conserved domains: (i) an N-terminal SSD domain (amino acids (aa) 169±286) which is found in all known homologues of mDac and shows a structural homology to the transforming domain of the proto-oncogene Ski and Sno; and (ii) a C-terminal alpha helical domain (aa 608-716) that is less conserved between Drosophila and mouse Dac but is found in other vertebrate Dac proteins (Hammond et al., 1998; Caubit et al., 1999; Kozmik et al., 1999) .
In the proto-oncogene Ski, the SSD domain is essential and suf®cient for the transformation and trans-activating activity. Hitherto it is not clear whether there is a functional relevance for the structural conservation between the SSD domain in Dac and Ski. As shown in Fig. 1A , neither the SSD domain-containing bait mDac 157±332 nor the extended N-terminus mDac 157±364 are suf®cient for the interaction with mUbc9 in the yeast two-hybrid system. In contrast, the C-terminal half Dac 365±751 binds to mUbc9 with equal ef®ciency as the full-length Dac. Since alpha helical domain of mDac (aa 590±685) as the bait also did not give positive colonies in the two-hybrid assay, we assume that the region responsible for the protein interaction is located between amino acids 365±590.
mUbc9 and mDac are expressed in complementary and overlapping areas in mouse embryos
To test whether mUbc9 and mDac are co-expressed, and thus capable of interacting in vivo, whole-mount in situ hybridizations were carried out. As depicted in Fig. 2 , mUbc9 is expressed in several areas where also mDac transcripts are detected, although we also observed complementary expression in particular in certain parts of forebrain. In the limb bud, the overlapping expression of mDac and mUbc9 is most apparent (Fig. 2C,D) . At 11.5 dpc, mUbc9 and mDac transcripts are found in the proliferation zone, mUbc9 expression appears to extend slightly more medial than mDac expression. At 12.5 dpc, mDac transcripts are found in the inter-digital zone and at the tip of the emerging digital rays. mUbc9 is also found in the inter-digital zone but again shows slightly broader expression. In the forebrain at stage 12.5 dpc (see Fig. 2E ,F), a complementary expression was observed with strong mDac signal in the cortex (C) that gradually weakens towards the medial (MGE) and lateral (LGE) ganglionic eminence where strong expression of mUbc9 was detected. The expression of both genes overlaps in the hippocampus. Remarkable complementary expression pattern occurs in the dorsal thalamus (T) where mUbc9 is found in the ventricular zone but mDac merely in a faint strip in the mantle zone. Complementary expression was also found in the preoptic area (POA).
Intracellular localization and protein stability of mDac
Provided that mDac interacts with mUbc9 in vivo, both proteins should at least temporarily be found in the same sub-cellular compartments. To address this question, human HeLa cells, Chinese hamster ovary cells (CHO) and mouse ®broblasts NIH/3T3 were transfected transiently with HAtagged mDac and c-myc-tagged mUbc9 under the control of a human cytomegalovirus (CMV) promoter. As shown in Fig. 3A , lane 1, full-length mDac was predominantly found in the nucleus in all examined cell lines, where it showed characteristic compartmentalization. This ®nding correlates In situ hybridization on whole-mount embryos. (A) mDac expression at 12.5 dpc. (B) mUbc9 expression at 12.5 dpc. Note the overlapping expression of both genes, particularly in limb buds, spinal cord and dorsal chain ganglia. (C) mDac expression in the fore limb at 12.5 dpc and in the proliferation zone of the fore limb at 11.5 dpc. (D) mUbc9 expression in the fore limb at 12.5 dpc and in the proliferation zone of the fore limb at 11 dpc. Note that the area of mUbc9 expression at 12.5 dpc extends further toward the digital rays compared to mDac. (E,F) in situ hybridization on coronal sections of E12.5 forebrain. mDac (E) is strongly expressed in cortex, hippocampus and in ventral preoptic area (POA). Note the strip of mDac expressing cells in the lateral edge of thalamus. mUbc9(F) is detected in the lateral and medial ganglionic eminence, cortex, hippocampus, ventricular zone of thalamus and preoptic area. C, cortex; LGE, lateral ganglionic eminence; MGE, medial ganglionic eminence; POA, preoptic area; T, thalamus.
with data by Mardon et al. (1994) who have shown that Drosophila Dac is a nuclear protein expressed in various imaginal discs. In dividing cells (lane 2), however, mDac protein translocated to the cytoplasm or condensed along the nuclear membrane, while mUbc9 was cytoplasmic regardless to the cell cycle in all examined cell lines. mUbc9 staining in the cytoplasm appears to be in contrast to predominant perinuclear localization of mUbc9 in HeLa cells as reported by Lee et al. (1998) . Intracellular localization of mDac in several cell lines might suggest that mDac shifts outside the nucleus and/or concentrates along the perinuclear zone in mitotic cells. To test this hypothesis, NIH/3T3 cells were starved in serum-deprived medium for 24 h. As expected, quiescent NIH/3T3 cells show solely nuclear staining (Fig. 3C) .
The two-hybrid assay revealed the C-terminal part mDac 365±751 facilitates interaction with mUbc9 whereas the N-terminus mDac 157±364 does not (see Fig. 1A ). We therefore examined the intracellular localization of these two deletions. The N-terminal portion was found in nuclei in all phases of the cell cycle. In contrast, the C-terminus mDac 365±751 was detected in cytoplasmic granules, which strongly resemble immunostaining of lysosomes, but not in the nucleus. Since computed bipartite nuclear localization signal (NLS) is located at the C-terminal half (aa 682±698), we assume that the dynamic localization of mDac in cultured cells is attenuated by mDac-interacting factors such as mUbc9.
In Drosophila, Dac forms a regulatory network with several nuclear factors including Ey. A vertebrate homologue of Ey, Pax6, has been reported to transform cultured cells (Maulbecker and Gruss, 1993) . In addition, the SSD domain of Ski is responsible for cell transformation activity of Ski. Thus, we were interested in whether mDac is similarly capable of transforming NIH/3T3 cells. No clear transformed colonies were obtained in a standard soft-agar cloning protocol (data not shown). Upon closer inspection it was apparent that all stably transfected NIH/3T3 clones did express high levels of mDac-HA mRNA, but mDac-HA protein was undetectable by immuno¯uorescence and Western blot analysis.
The mDac-mUbc9 interaction, which is revealed in the yeast two-hybrid system, might also implicate that mDac is a target for a post-translational modi®cation and subsequent proteolysis. mUbc9 has been proposed to conjugate ubiquitin (Firestein and Feuerstein, 1998) , although several recent studies have shown that mUbc9 conjugates ubiquitin homologue SUMO-1 rather than ubiquitin (Desterro et al. 1997; Giraud et al., 1998; Schwarz et al., 1998; Liu et al., 1999a) . Multiple roles of ubiquitin modi®cations of proteins in degradation by 20S/26S proteasome, targeting for endocytosis or in a functional alteration is well documented (for review see Hochstrasser, 1996) . On the other hand, a role of protein modi®cation by SUMO-1 has been thoroughly described only in the case of the RanGAP1 transport protein that associates with the nuclear pore complex upon modi®-cation with SUMO-1 (Mahajan et al., 1997; Lee et al., 1998; Matunis et al., 1998; Saitoh et al., 1998) . However, mUbc9 has also been reported to interact with poly-ADP ribose polymerase (PARP) (Masson et al., 1997) that is a part of 20S proteasome complex (Meyer-Kuckuk et al., 1999) . We therefore tested the possibility whether irreversible inhibition of 20S proteasome by lactacystin might lead to a protein stability of mDac. This drug inhibits a function of 20S proteasome by attaching to N-terminal Thr in MB1 subunit of 20S complex. Stably transfected NIH/3T3 cell clones with integrated mDac-HA gene under CMV promoter, which showed high levels of mDac transcripts but no immuno¯uorescence, were exposed to 50 mM lactacystin for 2 h, or 10 mM concentration for 4 and 24 h. Strikingly, a strong nuclear staining of mDac was detected 24 h after adding lactacystin to the medium (Fig. 3B) . A parallel experiment was performed in CHO cells. Likewise, lactacystin treatment of CHO stable clones led to strong appearance of mDac protein although no protein was detected in untreated cells. Assuming that mUbc9 activity accounts for the degradation of mDac, the non-interacting part of mDac should not be degraded in stable clones. The C-terminal half mDac 365±751 , which interacts with mUbc9, was degraded in stable NIH/3T3 and CHO clones and lactacystin treatment rescued protein stability. In contrast, the non-interacting Nterminus mDac 1±364 showed elevated protein stability that was not in¯uenced by an additional lactacystin treatment (Fig. 3D) .
To determine the intracellular localization of mDac in embryonic tissues we manufactured an anti-mDac polyclonal antibody. A Western blot analysis of 12.5 dpc embryos using mDac antiserum shows a double band in the range of 80 kDa (Fig. 4A ). This size corresponds reasonably well to the predicted molecular weight of the mDac proteins encoded by two splicing variants (Caubit et al., 1999) . The same set of mDac bands was detected in head and limb fractions of 12.5 dpc embryos indicating that both mDac splicing variants are present in various embryonic tissues. A band of approximately 80kDa was also detected after fulllength mDac cDNA had been translated in vitro (Fig. 1B) or after transfection of mDac cDNA into various cell lines (Fig. 4B) .
The binding speci®city of mDac antiserum was further examined by whole-mount antibody staining of mouse embryos. In 12.5 dpc mouse embryos (Fig. 5A±E) , mDac protein is present in tissues where mDac transcripts were detected (Hammond et al., 1998; Caubit et al., 1999; Kozmik et al., 1999) . Immunostaining was observed in the telencephalon, the eye, branchial arches 1 and 2, the dorsal nerve cord, dorsal chain ganglia and the proliferation zone of the limb buds. The intracellular localization of endogenous mDac (Fig. 5F±H) is not strictly nuclear, which correlates with our observation in transfected cells. In the proliferation zone of the limb buds nuclear membranes could not be clearly detected in most cells using standard histological staining methods. Immunostaining mDac was ubiquitous in such dividing cells and predominantly nuclear in the cells where nuclear membranes were apparent (Fig.  5H) . In the dorsal spinal cord, mDac was detected both in the cytoplasm and the nucleus (Fig. 5G) . Finally, we localized mDac protein in the cytoplasm of migrating neural crest cells (Fig. 5F ).
Discussion
Drosophila dac participates in a regulatory network that consists of mutual cooperations and positive feedback loops with factors including ey, eya, so and tsh (Chen et al., 1997; Pignoni et al., 1997) . In Drosophila eye development, Dac and Eya function synergistically and interact physically as has been demonstrated by using yeast two-hybrid and pulldown experiments (Chen et al., 1997) . Others and we have recently cloned a vertebrate homologue of Drosophila dac that is co-expressed in some areas with vertebrate homologues of ey, so and eya whereas the expression pattern does not overlap in other tissues. Only mEya2, one of three mouse homologues of Drosophila Eya, is capable of rescuing an eya null phenotype in the fruit¯y, indicating that mEya2 is a functional homologue of the Drosophila Eya . Surprisingly, we cannot con®rm a physical interaction between mDac and mEya2, although the yeast two-hybrid and in vitro protein binding assays, which showed an interaction of Dac-Eya in Drosophila but not mDac-mEya2 in vertebrates, have been carried out under similar experimental conditions. These methods may not detect a weak mEya2-mDac interaction or such association depends on post-translational modi®cations in vertebrate cells and/or it requires additional factors. Although these possibilities remain to be veri®ed we have searched for other possible mDac binding factors. The results of two independent yeast two-hybrid screens suggest a strong af®-nity between mUbc9 and mDac. This interaction was also demonstrated in pull-down experiments. In this context it would be worthwhile to analyze whether Dac can associate with Ubc9 also in Drosophila.
Ubc9 plays critical roles in number of processes including cell-cycle control, modulation of activity of transcription factors, nuclear protein transport and stability. In yeasts, Ubc9 is a member of the E2-type ubiquitin-conjugating enzyme family and is essential for cell cycle progression and cell viability (Al-Khodairy et al., 1995; Hateboer et al., 1996) . Repression of Ubc9 synthesis leads to a stabilization of S-phase cyclin CLB5 and M-phase cyclin CLB2 that prevents progression of cell cycle at the G2 or early M phase (Seufert et al., 1995) . Vertebrate homologues of Ubc9 also interfere with pathways that control cell cycle. Adenovirus E1A proteins type 5 and 12 (Hateboer et al., 1996) and mouse E2A (Kho et al., 1997; Loveys et al., 1997) have been documented to interact with mouse Ubc9. Human Ubc9 (hUbc9), which is 100% identical to the mouse homologue in its amino acid sequence, associates with Rad51 (Kovalenko et al., 1996) and poly (ADP-ribose) polymerase (PARP) (Masson et al., 1997) . Both proteins function in a DNA repair machinery that relates to cell-cycle control. Dac null mutants in Drosophila show severely reduced or absent eyes and condensed intermediate leg segments. Mouse dac is expressed in a variety of highly proliferating tissues, in the proliferation zone of the limb bud in particular. It is attractive to speculate that mDac-mUbc9 interplay in¯u-ences a balance between the cell cycle progression and apoptosis.
Most ubiquitin-conjugating proteins function in the 20S proteasome pathway. For instance, the Ubc9-interacting protein PARP associates directly with the 20S proteasome (Meyer-Kuckuk et al., 1999) . Along this line, antisense Ubc9 reduces E2A degradation (Kho et al., 1997) and protein stability of ATF2 is dependent on the hUbc9 activity (Firestein and Feuerstein, 1998 ). Here we report that fulllength mDac protein is ultimately degraded in NIH/3T3 and CHO cell clones that integrated and transcribe mDac-HA. However, mDac has been rescued in stable clones by inhibition of the S20 proteasome with lactacystin. If mUbc9 is a part of S20 multiprotein complex and is involved in the degradation of mDac, the truncated mDac, which does not associate with mUbc9, ought to be more stable than fulllength protein. Indeed, the N-terminal half mDac 1±364 was found to be more resistant to degradation than full-length protein or its C-terminus and lactacystin treatment did no longer increase the protein level in the same clones. mDac cleavage cannot be, however, entirely explained by its association with mUbc9 since we observed the protein expression only in 30% of the selected clones. Nevertheless in our transient transfections the HA-tagged mDac was clearly detected. This may be due to the fact that a presence of small HA epitope is suf®cient for immunostaining while the protein has been cleaved or it may re¯ect an overloading of the proteasome pathway in cells that strongly overexpress the mDac-HA.
Vertebrate Ubc9 may be functionally distinct from other E2-type ubiquitin-conjugating enzymes since it facilitates coupling of SUMO-1 (small ubiquitin-related modi®er-1) but not the ubiquitin (Desterro et al., 1997 (Desterro et al., , 1999 Schwarz et al., 1998) . The post-translational modi®cation by SUMO-1 has been reported to affect targeting to speci®c cellular compartment. SUMO-1 coupling to RanGAP1 is essential for localizing of the RanGAP1 to nuclear pore complex (Mahajan et al., 1997; Matunis et al., 1998) and this process is dependent on the hUbc9 activity (Lee et al., 1998) . Interestingly, a transport of the bicoid gene product to the nucleus is blocked in mutations in semushi gene which encodes a Drosophila homologue of Ubc9 (Epps and Tanda, 1998) . This leads to misregulation of segmentation genes that are bicoid targets. Our cell culture experiments and protein staining of various embryonic tissues show that mDac protein is found in the nucleus and/or in the cytoplasm. In quiescent cells, mDac was repeatedly detected only in nuclei whereas in the course of mitosis this protein condenses along the nuclear membrane in the cytoplasm. The shift of mDac was not observed when we used the deletions of mDac in transfection experiments. The Nterminus, which does not interact with mUbc9 in the yeast two-hybrid assay, is permanently stained in nuclei. On the contrary, the interacting C-terminus is located in the cytoplasm in the form of small granules although this region encompasses the bipartite NLS. Reported staining of lysosomes with commercial antibodies (e.g. LysoTracker Red manufactured by Molecular Probes) shows almost identical pattern suggesting that C-terminal half of mDac is localized in lysosomes. Since mDac protein must be stable under certain conditions in natural context, we propose that the N-terminus contains signals conferring a protein stability.
It is appealing to speculate that mDac turnover can be in¯uenced by the interaction with mUbc9. Our results provide a new insight into regulatory mechanisms of mouse Dac function in the process of mouse development. The questions that are emerging in the context of mDacmUbc9 interaction are currently being analyzed in transgenic mice.
Experimental procedures
4.1. Yeast two-hybrid screening mDac cDNA (bp position 482±2256, EMBL/GenBank accession number AF090436) was cloned into the SmaI site of pAS2-1 (Clontech, Palo Alto, CA). A SmaI restriction site was generated by PCR at bp 482 of mDac to create a fusion protein between the GAL4 activation domain and mDac (aa 157±751). The resulting construct, mDac 157±751 , was veri®ed by sequencing. mDac 157±751 was used as a bait in the two-hybrid screening of: (i) a mouse 11-day embryo MATCHMAKER cDNA library based on a GAL4 activation domain (Clontech); and (ii) a mouse 10.5 dpc embryo cDNA library based on VP16 activation domain (kind gift from S. Hollenberg, Wollum Institute, Oregon Health Science University). The bait and prey DNA were co-transfected into yeast strain CG1945 and screening procedures were performed according to the manufacturer's protocol. For deletions, 513-, 615-and 282-bp fragments of mDac corresponding to amino acids 157±332, 157±364 and 590± 685, respectively, were subcloned to the bait vector pAS2-1 and co-transfected with mUbc9. To test for a possible mDac-mEya2 interaction, the full-length mouse Eya2 cDNA (aa 1±532; Xu et al., 1997) and a 897-bp DNA fragment encompassing a conserved region of mEya2 (aa 231± 532) were inserted in-frame into pGAD10 vector (Clontech) and co-transfected with mDac 157±751 . Yeast two-hybrid cotransfections with mDac 157±752 into yeast strain CG1945 and screening procedures were performed according to the manufacturer's protocol (Clontech).
GST pull-down assay
The full-length cDNAs of mUbc9 and mEya2 were cloned in-frame into pGEX4T vectors (Pharmacia; Uppsala, Sweden). The GST fusion proteins were coupled to glutathione agarose beads (Sigma, St. Louis, MO) following expression in bacterial strain PS1. The [ 35 S]-labeled mDac protein was obtained by in vitro transcription and translation of mDac complete cDNA using rabbit reticulocyte lysate (Promega; Madison, WI). Equal amounts of radiolabeled mDac protein were incubated with 1 mg of puri®ed GST protein fusions or GST alone that had been coupled to the beads. Fifty percent slurry in binding buffer (50 mM Tris± HCl pH 7.6 et al., 100 mM NaCl, 0.1% NP-40 et al., 10% glycerol, 0.1 mM EDTA, 1 mM DTT) was rocked slowly for 2.5 h at 48C in the presence of complete protease inhibitor cocktail (Boehringer, Mannheim, Germany). After four washes in excess of binding buffer at 48C, the beads were resuspended in 2£ SDS sample buffer, brie¯y boiled and loaded on a 10% SDS-polyacrylamide gel.
Cell culture, transfections and immunostaining
NIH/3T3 mouse ®broblasts and human HeLa cells were maintained in Dulbecco's-modi®ed Eagle's medium and F12 (1:1) supplemented with 10% fetal calf serum (Gibco; Paisley, UK). Chinese hamster ovary cells (CHO) were cultured in the same mixture with 5% serum. mUbc9 and mDac cDNAs were tagged at the C-terminal end with a cmyc epitope and HA-epitope, respectively. Tagged mDac and mUbc9 cDNAs were cloned into the mammalian expression vector pCI-neo (Promega) and subsequently referred to as pCI-neo-dacHA and pCI-neo-ubc9cmyc, respectively. Transfections were carried out using FUGENE6 (Boehringer Mannheim) following the instructions provided by the manufacturer. Forty-eight hours posttransfection, cells were washed with PBS and ®xed in prewarmed 4% paraformaldehyde in 200 mM HEPES, pH 7.4 for 15 min and subsequently permeabilized in 0.1% Triton X-100 in PBS for 15 min. Following saturation with a solution of 5% bovine serum albumin (BSA), cells were stained with anti-HA monoclonal antibody (mAb) 12CA5 or anti-c-myc mAb 9E10 in PBS containing 1% BSA and 0.1% Tween 20 (PBST). After three washes with PBS, a secondary¯uorophore-labeled anti-mouse antibody Alexae 594 (red) or 488 (green) (Molecular Probes, Eugene, OR) was added to PBST and the cells were incubated for 30 min at room temperature. Nuclei were visualized with DAPI (Boehringer, Mannheim, Germany) according to the manufacturer's protocol after the immunostaining had been completed.
Antibodies and Western blot analysis
A 1164-bp fragment of the mDac cDNA corresponding to aa 365-751 was cloned into pGEX4T-2 (Pharmacia). The resulting GST-Dac 365±751 fusion protein was expressed in E. coli strain PS1 and puri®ed using glutathione-agarose beads (Sigma). Antibodies against the fusion protein were raised in rabbits by Eurogentec Bel S.A., Belgium. Polyclonal antiserum was used for Western blot analysis and immunohistochemistry on whole-mount embryos. To obtain protein extracts, cultured cell lines in 100-mm tissue culture dishes were transfected with pCI-neo-dacHA as described above. Forty-eight hours post-transfection, the cells were lysed by adding 150 ml of 2£ SDS sample buffer. After sonication for 5 s, the mixtures were boiled for 5 min and 7 ml of the protein extracts were loaded on 10% SDS-polyacrylamide gel. The proteins were transferred onto a PVDF membrane (Milipore; Bedford, MA) and stained with 1:200 diluted anti-Dac polyclonal serum in the presence of 5% milk in PBST. Bands were visualized using anti-rabbit alkaline phosphatase (Boehringer Mannheim) and CDP Star Chemiluminescence reagent (Boehringer Mannheim) as the substrate.
In situ hybridization on whole-mount embryos
In situ hybridization experiments were performed as described previously (Caubit et al., 1999) . mDac cloned in pBluescript was linearized with EcoRI and transcribed with T7 RNA polymerase to obtain a 1164-bp digoxigeninlabeled riboprobe. Full-length mUbc9 in pCI-neo was linearized with EcoRI and transcribed with T3 RNA polymerase.
In situ hybridization on tissue sections
The embryos was dissected and ®xed overnight at 48C in 4% paraformaldehyde in PBS and embedded in agarose. After soaking in 30% sucrose in PBS 10±15 mm cryosections were prepared. Digoxigenin-labeled probes were used the same as for the whole-mounts. The hybridization (concentration of the riboprobes 0.5 mg/ml) was carried out overnight in hybridization buffer (1.95 M NaCl, 50 mM NaH 2 PO 4 , 50 mM Na 2 HPO 4 , 50 mM EDTA, 130 mM Tris±Cl, pH 7.5, 50% formamide, 10% dextrane sulfate, 1 mg/ml tRNA, 1£ Denhardt's) at 728C for mDac and at 738C for mUbc9 staining. After washing the probes were visualized with an alkaline phosphatase-conjugated anti-digoxigenin antibody (dilution 1/2500).
Immunohistochemistry on whole-mount embryos
Whole-mount embryos were ®xed overnight at 48C in methanol/DMSO (4:1) and stained with anti-Dac polyclonal serum (dilution 1:200) as described (Hogan et al., 1994) . The presence of mDac protein was visualized with anti-rabbit IgG peroxidase conjugate (Sigma) and SIGMA FAST DAB peroxidase substrate tablets (Sigma). For histological sections, ®xed samples stored in PBS were dehydrated followed by a subsequent 4 h in®ltration in Tecnovit 7100 (Heraeus Kultzer; Friedrichsdorf, Germany). Specimens were transferred to resin containing hardening agent (1±15 ml resin) and were polymerized at room temperature. Sections of 7 mm were cut with glass knives, transferred to slides and dried. Nuclei staining was performed using 0.5% Nuclear Fast Red* IA 402 (Chroma-Gesellschaft; Ko Èngen, Germany) for 3 min.
